Clinical Trial: An Exploratory Clinical Study on the Safety and Efficacy of Autologous NK Cells in the Treatment of Pulmonary Nodules

U.S., Sept. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07185035) titled 'An Exploratory Clinical Study on the Safety and Efficacy of Autologous NK Cells in the Treatment of Pulmonary Nodules' on Sept. 15.

Brief Summary: A single-center, open-label dose-escalation design to evaluate the safety and efficacy of KN5001 in patients with pulmonary nodules.

Study Start Date: Sept. 20

Study Type: INTERVENTIONAL

Condition: Pulmonary Nodules, Solitary Pulmonary Nodules, Multiple

Intervention: BIOLOGICAL: KN5001

Subjects will receive KN5001 on day0, 3, and 6. Multiple Doses of KN5001 will infused using the "3 + 3" dose-escalation strategy.

Recruitment Status: RECRUITING

Sponsor: The First Affiliated Hospi...